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Background: Computerized clinical trial recruitment support is one promising field for the application of routine
care data for clinical research. The primary task here is to compare the eligibility criteria defined in trial protocols
with patient data contained in the electronic health record (EHR). To avoid the implementation of different patient
definitions in multi-site trials, all participating research sites should use similar patient data from the EHR.
Knowledge of the EHR data elements which are commonly available from most EHRs is required to be able to
define a common set of criteria. The objective of this research is to determine for five tertiary care providers the
extent of available data compared with the eligibility criteria of randomly selected clinical trials.
Methods: Each participating study site selected three clinical trials at random. All eligibility criteria sentences were
broken up into independent patient characteristics, which were then assigned to one of the 27 semantic categories
for eligibility criteria developed by Luo et al. We report on the fraction of patient characteristics with corresponding
structured data elements in the EHR and on the fraction of patients with available data for these elements. The
completeness of EHR data for the purpose of patient recruitment is calculated for each semantic group.
Results: 351 eligibility criteria from 15 clinical trials contained 706 patient characteristics. In average, 55% of these
characteristics could be documented in the EHR. Clinical data was available for 64% of all patients, if corresponding
data elements were available. The total completeness of EHR data for recruitment purposes is 35%. The best
performing semantic groups were ‘age’ (89%), ‘gender’ (89%), ‘addictive behaviour’ (74%), ‘disease, symptom and
sign’ (64%) and ‘organ or tissue status’ (61%). No data was available for 6 semantic groups.
Conclusions: There exists a significant gap in structure and content between data documented during patient care
and data required for patient eligibility assessment. Nevertheless, EHR data on age and gender of the patient, as
well as selected information on his disease can be complete enough to allow for an effective support of the
manual screening process with an intelligent preselection of patients and patient data.
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Together with the growing amount of clinical data collected
during patient care, the desire to gain access and to use
these data for purposes not related to patient care grows
alike [1]. Clinical researchers, quality management, ac-
counting and certification agencies propose a wealth of sce-
narios to which the supposed knowledge could be applied.
[2] One important application of secondary use is the iden-
tification of patients for recruitment into clinical trials [3].
The primary task here is to compare the eligibility criteria
defined in study protocols with patient data contained in
the electronic health record (EHR). Technical challenges
arising from the non-structured representation of eligibility
criteria within study protocols have been met with success-
ful demonstrations of intermediate formats, such as Arden
Syntax [4], ad hoc expressions [5] and Logic-based lan-
guages [6]. A comprehensive review can be found by Weng
et al. [7]. Likewise, systems for automated or semi-
automated transformation of eligibility criteria into these
computable formats have been developed [6,8].
No EHR can contain patient data on all possible eligi-
bility criteria. Practical applications of systems for re-
cruitment support were thus generally limited to ‘a set
of coarse criteria, and on information that is likely to be
available in the patient record’ [3]. In current recruit-
ment systems this set of criteria depends on the contents
of each local EHR. However, for multi-centre studies a
set of common criteria shared by all participating re-
search sites is preferable to ensure that all hospitals in-
clude patients with the same characteristics. In order to
determine this set of common criteria, the commonly
available EHR contents must be taken into account.
A review on the content and quality of EHR data has
been presented by Chan, Fowles and Weiner [9]. However,
to our knowledge the currently available literature has lim-
itations. While the general content of the EHR has been
investigated for primary care practices, for example by
Pringle et al. [10] and Scobie et al. [11], investigations re-
garding the EHR of tertiary care providers have been lim-
ited to single health conditions like HIV [12] or pancreatic
cancer [13]. Furthermore, all studies need to focus on a se-
lection of data elements, which are defined by the purpose
of the investigation. Obviously, an investigation regarding
the availability of EHR data for the purpose of patient re-
cruitment should derive its data elements of interest from
a random set of real world eligibility criteria. But while the
contents of these criteria have recently been described by
Luo et al. [14], no comparison with the content of a set of
real life EHRs is yet available.
The objective of this research is to determine to what
extent the patient data requested in eligibility criteria of
clinical trials is available from the EHR of tertiary care
providers. The research is conducted by five German
university hospitals with different EHR systems.Methods
Five German university hospitals located in Münster,
Erlangen, Düsseldorf, Heidelberg and Gießen agreed to
participate in this research. All hospitals are large tertiary
care centres with 1,200 to 1,900 beds. Each site applies
another EHR system: Orbis (Agfa) is used in Münster,
Soarian Clinicals (Siemens) in Erlangen, i.s.h.med
(Siemens) in Heidelberg, Medico (Siemens) in Düsseldorf
and a proprietary development named KAOS in Gießen.
These systems cover 94% of the EHR products used in all
33 German University Hospitals. All EHR systems offer a
single point of access to most of the patient data that is
documented during patient care. To achieve this, they im-
port data from a multitude of specialty specific systems
like the laboratory, the surgery, the intensive care and the
patient management system. It is also possible to enter
data directly into the EHR by designing custom assess-
ment forms which consist of a set of data elements like
free text and numeric fields, checkboxes and multiple
choice questions. The content of the EHR is determined
by the individual requirements of the hospital administra-
tion and the clinical departments.
Each hospital compared the eligibility criteria of three
trials with the patient data available from its local EHR.
The set of studies was selected individually for each hos-
pital. Selected trials had to meet the following conditions:
(1) The disease under investigation was still treated by the
same department that conducted the trial. (2) The permis-
sion to process the clinical data of all patients from that
department could be obtained. (3) The trial was not spon-
sored by a pharmaceutical company.
In the trial descriptions from clinicaltrials.gov, eligibil-
ity criteria are provided in free text sentences. These
sentences can be logically and grammatically complex
and contain, for example, Boolean or conditional expres-
sions. The original form of these criteria is therefore ill
suited for direct comparison with the more structured
data elements in the EHR, which usually hold only a sin-
gle piece of information. As a consequence, we broke up
all eligibility criteria sentences into independent patient
characteristics. We define a patient characteristic as a
single fact that is needed to evaluate an eligibility criter-
ion for a given patient. To assess for example the criter-
ion ‘Lupus nephritis with renal biopsy performed within
one year prior to screening’ the two characteristics ‘pa-
tient suffers from lupus nephritis’ and ‘date of renal bi-
opsy’ must be known. All logical relations between these
characteristics as stated in the criterion’s original free
text sentence were discarded in this process.
Clustering of the patient characteristics by content is ne-
cessary to allow a meaningful presentation of results. For
this reason, all characteristics were manually assigned to
one of the 27 semantic categories defined for eligibility cri-
teria by Luo et al. [14]. This research group recently used
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tering on 4.821 randomly selected eligibility criteria to
identify 27 semantic categories in six topic groups. The
topic groups are: ‘health status’, ‘lifestyle choice’, ‘treatment
or healthcare’, ‘diagnostic or lab result’, ‘demographics’ and
‘ethical consideration’. Five authors each assigned all eligi-
bility criteria of 3 studies to one of the semantic categories.
Two authors validated the results. The distribution of the
criteria over the semantic categories was compared with
the results reported by Luo et al. to assess the representa-
tiveness of the given trials.
In the next step, each patient characteristic was matched
to its corresponding data elements in the EHR. We de-
fined corresponding data elements of a patient character-
istic as those fields in the EHR’s database which hold for
at least one patient the information whether the patient
has the characteristic or not. Corresponding data elements
were identified by (1) individual knowledge of the database
administrators, (2) searching for keywords in the EHR
metadata (for example in the names of laboratory values
or assessment form elements) and (3) involvement of the
clinical staff, which actually generates the clinical docu-
mentation during patient care. Only numeric and struc-
tured element types like checkboxes and drop down
menus were included, as none of the participating hospi-
tals had the means to reliably extract information from
free text data elements. The terminology used in this
paper is summarized in Figure 1.
Completeness of EHR data for the purpose of patient
recruitment depends on two conditions. First, data ele-
ments need to exist, which enable the physician to docu-
ment a given patient characteristic. If an EHR lacks the
necessary data elements, no data will be available for the
characteristic. For each semantic category, we calculated
the fraction of documentable patient characteristics as
the fraction of patient characteristics with at least one
corresponding data element. Second, even if correspond-
ing data elements are offered by the EHR, data will be
incomplete, if these data elements are not filled in by the
clinicians. We calculated for each patient characteristic
the fraction of patients with any data in at least one of
its corresponding data elements. The calculation in-
cluded all patients admitted in the fourth quarter of
2011 to the clinical department that conducted the trial.
The results are presented as average values grouped by





Figure 1 Terminology used in our study. Detailed legend: Each trial con
investigation. Each criterion contains one to n patient characteristics, which
a given patient. Each patient characteristic can be mapped to 0 to n data e
the characteristic.data for the purpose of eligibility determination for clin-
ical trials was calculated by multiplication of the fraction
of patient characteristics with corresponding data ele-
ments with the fraction of patients with any data in
these data elements.
Results
The 15 trials (see Table 1) comprised at least 3, at most 49
and in total 351 eligibility criteria. Half of the criteria de-
scribed only one patient characteristic, while the other half
required data on 2 to 16 characteristics. After decompos-
ition we obtained 706 patient characteristics. Each trial
contained between 11 and 122 patient characteristics. After
manual assignment of each patient characteristic to one of
the semantic categories we found a quantitative distribution
very similar to that described by Luo et al. (see Table 2). Six
categories did not appear in our trials: bedtime, exercise,
device, receptor status, address and ethnicity. We were not
able to relate 22 (3%) of our patient characteristics to the
proposed categories, mainly because they did not focus on
the patient, but on the cause of a symptom (‘organ dysfunc-
tion not explained by any chronic disease’), on the outcome
(‘failed conservative therapy’) or on specifics of the treat-
ment or the environment of the patient (‘[method of]
contraception results in a failure rate less than 1% per
year’). Two thirds of all information needed to assess the
eligibility of a patient for a trial were related to his disease
history (health status and diagnostic or lab test), while an-
other 16% related to his treatment history (Treatment or
Health Care).
After clustering of all patient characteristics in seman-
tic categories, we subsequently (1) matched these char-
acteristics to corresponding data elements, (2) calculated
the fraction of patients with some value for at least one
of those data elements and (3) calculated overall data
completeness. The results of these three steps are sum-
marized for each topic group. Average values for each
semantic group are displayed in detail in Table 3.
Health status
Corresponding data elements were found for 192 (60%) of
318 patient characteristics in the topic group ‘health sta-
tus’. In 123 (39%) cases the participating hospitals trans-
lated the characteristic into one or more codes from the
International Classification of Diseases (ICD). Beyond the





tains 1 to n eligibility criteria to describe the patient population under
must be known in order to evaluate whether the criterion is true for
lements in the EHR, which hold the relevant data regarding
Table 1 Selection of trials included into our study
Hospital Study identifier Disease Parent population Number of criteria
Münster NCT01177033 intermittent claudication 299 18
Münster NCT00976222 pigment epithelial detachment 3330 25
Münster NCT00961142 acute leukemia 2065 39
Erlangen NCT00866684 skin cancer 10589 21
Erlangen NCT00025402 chronic myelogenous leukemia 1806 16
Erlangen NCT00310583 mechanical hyperalgesia 4438 31
Heidelberg NCT01165671 primary glioblastoma 22280 22
Heidelberg NCT00176150 anorexia nervosa 22280 3
Heidelberg NCT00750971 lupus erythematosus 22280 21
Düsseldorf NCT00798525 critical illnesses 708 13
Düsseldorf NCT00933374 urothelial carcinoma 2091 40
Düsseldorf NCT00977132 myelodysplastic syndrome 2351 30
Gießen DOI 10.1111/j.1365-2044.2012.07303.x general anaesthesia 5500 7
Gießen NCT01146821 sepsis 208 49
Gießen DRKS00003264 abdominal surgery 5500 16
Detailed legend: Each participating hospital selected 3 clinical trials, for which the study identifier, the disease under investigation, as well as the size of the parent
population and the number of eligibility criteria are given in this table. Study identifiers beginning with NCT are related to clinicaltrials.gov and the identifier
beginning with DRKS relates to the German register germanctr.de. One trial was not registered and thus has no identifier. For this study we show the digital
object identifier (DOI) of the publication of the trial’s results. The parent population includes all patients admitted in the fourth quarter of 2011 to the clinical
department that conducted the trial.
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sessment forms depends heavily on the preferences of each
clinical department and thus exhibited a wide variability be-
tween the participating hospitals. The semantic categories
in the group ‘health status’ are therefore divided into two
groups. On the one hand, ‘disease, symptom and sign’, ‘organ
or tissue status’ and ‘neoplasm status’ are well covered by
the ICD catalogue. Therefore 74 to 81% of the patient char-
acteristics belonging to these categories were found in the
EHR and the corresponding data elements were populated
for about 80% of all patients. On the other hand, gaps seem
to exist in the ICD catalogue for characteristics from the
categories ‘allergy’, ‘disease stage’, and ‘pregnancy-related ac-
tivities’. While corresponding data elements existed in indi-
vidual hospitals, these were not common to all, resulting in
a poor average data completeness of only 6 to 12%. No data
elements were found to contain information on the life ex-
pectancy of a patient. The overall data completeness in this
topic group was 46%.
Diagnostic or lab test
All studies together requested 137 patient characteristics
from the topic group ‘diagnostic or lab test’. The possibil-
ity to document the necessary information electronically
and in a structured way was given for 74 (54%) of them.
Though both were included in one semantic category by
Luo et al., diagnostic and laboratory data differed regard-
ing data completeness. Diagnostic data is often measured
manually by physicians and nurses. Currently, these re-
sults are commonly documented in paper charts ratherthan in the EHR. In contrast, laboratory and monitoring
devices deliver their test results to the physician by elec-
tronic means. Thus laboratory data was generally available
in a structured format from the EHR. However, challenges
arose in identifying data elements corresponding to these
patient characteristics, as all five hospitals use individual
terminologies rather than LOINC (Logical Observation
Identifiers Names and Codes) [15] for data description.
Identified data elements for diagnostic and laboratory data
were populated for approximately one third of all patients.
For this reason, the average data completeness of patient
characteristics from this topic group was only 20%.Treatment or health care
We assigned 124 patient characteristics to the topic group
‘treatment or health care’. Corresponding data elements
were found for 71 (57%) of these characteristics. In 46
(37%) cases, the characteristics were encoded with the
‘Operationen- und Prozedurenschlüssel’ (OPS) catalogue,
which is the German modification of the International
Classification of Procedures in Medicine (ICPM). Fields
from individually designed assessment forms were again
chosen as the second data source, where codes were un-
available. Corresponding data elements were identified for
74% of the characteristics from the semantic category ‘ther-
apy or surgery’, but these were in average only populated
for half of all patients, resulting in a data completeness of
34%. Structured data on a patient’s medication is currently
almost non-existing. Only 35% of the characteristics could
Table 2 Eligibility criteria distribution according to
semantic categories
Luo et. al. This research
[%] [%] n
Health Status 43.72 45.04 318
Disease, Symptom and Sign 29.21 22.52 159
Pregnancy-related activity 5.17 5.24 37
Neoplasm status 3.67 3.40 24
Disease stage 2.20 2.27 16
Allergy 2.15 5.95 42
Organ or tissue status 0.73 5.38 38
Life expectancy 0.59 0.28 2
Treatment or Health Care 20.74 17.56 124
Pharmaceutical substance or drug 12.84 7.37 52
Therapy or surgery 7.61 10.20 72
Device 0.29 - 0
Diagnostic or lab test 14.85 19.41 137
Diagnostic or lab results 14.63 19.41 137
Receptor status 0.22 - 0
Demographics 8.79 4.67 33
Age 5.91 2.69 19
Special patient characteristic 1.18 0.42 3
Literacy 0.65 0.28 2
Gender 0.41 1.27 9
Address 0.35 - 0
Ethnicity 0.29 - 0
Ethical Consideration 8.52 8.64 61
Consent 2.76 2.55 18
Enrolment in other studies 2.38 1.27 9
Capacity 1.50 3.54 25
Patient preference 1.38 0.57 4
Compliance with protocol 0.50 0.71 5
Lifestyle Choice 3.38 1.56 11
Addictive behaviour 2.09 1.42 10
Bedtime 0.47 - 0
Exercise 0.44 - 0
Diet 0.38 0.14 1
no fitting category - 3.12 22
Detailed legend: Distribution of the 706 patient characteristics from 15 clinical
trials according to the semantic categories developed by Luo et al. and
comparison with the distribution obtained by Luo et al. for 4821
eligibility criteria.
Table 3 Completeness of patient information in German
electronic health records
D F C
Health Status 0.60 0.77 0.46
Disease, Symptom and Sign 0.81 0.79 0.64
Pregnancy-related activity 0.16 0.38 0.06
Neoplasm status 0.75 0.79 0.59
Disease stage 0.25 0.45 0.11
Allergy 0.17 0.69 0.12
Organ or tissue status 0.74 0.82 0.61
Life expectancy 0 - 0
Lifestyle Choice 0.82 0.82 0.67
Addictive behaviour 0.90 0.82 0.74
Diet 0 - 0
Treatment or Health Care 0.57 0.44 0.25
Pharmaceutical substance or drug 0.35 0.17 0.06
Therapy or surgery 0.74 0.46 0.34
Diagnostic or lab test 0.54 0.36 0.20
Diagnostic or lab results 0.54 0.36 0.20
Demographics 0.85 0.91 0.77
Age 0.95 0.94 0.89
Special patient characteristic 0.33 0.76 0.25
Literacy 0 - 0
Gender 1.00 0.89 0.89
Ethical Consideration 0.08 0.71 0.06
Consent 0.06 0.50 0.03
Enrolment in other studies 0 - 0
Capacity 0.16 0.76 0.12
Patient preference 0 - 0
Compliance with protocol 0 - 0
Total 0.55 0.64 0.35
Detailed legend: D = fraction of documentable patient characteristics, i.e. at
least one data element containing data on this characteristic was found,
F = Average fraction of patients with any data documented in one of these
data elements, C = average completeness of patient data for patient
characteristics from the semantic category (C=DxF).
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were empty for 83% of the patients.
Ethical consideration
Only 5 of 61 characteristics in the topic group ‘ethical
consideration’ were found for at least one patient in astructured form. This was not due to an insufficiency of
the documentation systems but rather to the nature of
the required characteristics itself. Data for items from
the semantic categories ‘compliance with protocol’ and
‘consent’ are available only after inclusion into the trial.
In three cases, questions regarding the capacity of the
patient to participate in the trial could be translated to a
number of diseases, but more often they were too
dependent on the interpretation by the investigator. Fi-
nally, while 9 out of 15 trials exclude patients who are
enrolled in other trials, this fact is not yet documented
in the EHR and thus cannot be taken into consideration.
With 6% total data completeness information on
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ation’ does virtually not exist.
Demographics
Characteristics considering age and gender of a patient are
available from the EHR for almost every case. No data ele-
ments corresponding to the patient’s literacy were found.
Three characteristics from the category ‘special patient
characteristics’ asked for the patient’s healthiness, his fam-
ily history and whether or not he was detained. Here, only
the one characteristic regarding family history was avail-
able from structured data elements.
Lifestyle choice
10 out of 11 criteria in the topic group ‘lifestyle choice’
regarded a patient’s addictive behaviour i.e. his potential
drug or alcohol abuse. Both can be documented as ICD
codes which is why both a high possibility to document
these characteristics and usage of the corresponding data
elements are reported. Often the daily or weekly dose is
also documented as free text in assessment forms, but
cannot be evaluated automatically by the participating
hospitals yet.
In total, the existing EHRs offered an opportunity to
document data for 55% of the patient characteristics re-
quired to assess the patient’s eligibility for 15 trial proto-
cols. The corresponding data elements were populated
for 64% of all patients. Thus the average completeness of
patient data was 35%.
Discussion
Five hospitals analysed the completeness of patient data
required for patient recruitment into 15 randomly selected
clinical trials. In average, about half of all patient charac-
teristics mentioned in the trials’ eligibility criteria could be
documented in structured data elements within their
EHR. When a corresponding data element existed it was
populated on average with data for two thirds of the pa-
tients. While overall completeness of data for patient re-
cruitment was thus only 35%, some semantic categories
were more complete than others.
On the one hand, information on the age and gender of
a patient is complete for 90% of the patients. Data on the
disease, which is currently treated, is complete for 60% of
the characteristics and patients. On the other hand,
comorbidities and medication are currently only available
for about 10% of all patients. Primarily, data elements for
billing purposes and laboratory data are available in a
structured format. The remaining information generated
during patient care is generally captured in paper charts
or electronically as free text. The inclusion of the latter for
secondary use purposes is likely to improve data com-
pleteness, but none of the participating hospitals had the
necessary tools to transform free text into structured data.Eligibility assessment for clinical trials will require
patient data to be relatively complete for all observed
patients. Unfortunately, the absence of patient conditions
is usually not recorded during treatment which leads to
missing data. Evaluating patient eligibility based on partly
missing data risks missing eligible patients and the intro-
duction of selection errors if the distribution of missing
data is not completely random. The decision whether
missing data for a specific patient characteristic can be
interpreted as absent condition or whether the available
data is insufficient for evaluation can only be made indi-
vidually. It depends on the patient characteristic, the cor-
responding data elements and how they are used.
Therefore, while our results show fractions of missing data
of up to 83% (average 36%), this does not necessarily mean
that these characteristics cannot be used for eligibility
assessment. It does however indicate the risk of introdu-
cing selection errors. We believe that manual review and
additional documentation will remain necessary for most
clinical trials.
Our final result of 35% completeness of data is larger
than an estimation made by El Fadly et al. [16] who found
only 13% of the data elements required for one trial in
their EHR. Other studies are restricted on specific data el-
ements or a limited patient population. The data com-
pleteness of 20% for lab results found in our study is
similar to that identified by McGinnis et al. [17] (9 labora-
tory results, completeness: 1% to 37%, average: 14%) and
Persell et al. [18] (5 laboratory results, completeness: 1.9%,
22.5%, 29.1%, 25.3%, 23.3%). In a review of 4 papers
conducted by Thiru et al. [19] in 2003, data completeness
for 13 diseases ranged between 40 and 100% with an aver-
age of 86%, which is 20% more than our result. The broad
definition of the corresponding semantic category ‘disease,
symptom and sign’ by Luo et al. might explain this
difference.
Luo et al. developed their clusters for entire eligibility cri-
teria sentences on the premise, that ‘each eligibility criterion
sentence is an independent patient characteristic’. The eligi-
bility criteria for the 15 studies in our research did in fact
consist of several patient characteristics in half of the cases.
Nevertheless, assigning these characteristics individually to
the semantic groups yielded a distribution very similar to
that of Luo et al. While all assignments were checked by at
least two of the authors and while most categories were
very straightforward, the whole process was manual and
thus mismatches cannot be excluded. The number of char-
acteristics in each category, which is given in Table 2, might
be a good indicator on how sensitive the results for this cat-
egory are to mismatching. The average results for all eligi-
bility criteria are not influenced by their distribution.
In an analysis of 1000 random eligibility criteria Ross
et al. [20] found 6.8% of the criteria to be incomprehensible,
19% to require clinical judgement and 24% to require
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ion itself. They conclude that ‘researchers trying to deter-
mine patient eligibility for studies face incomprehensible
and ambiguous criteria as well as under-specified criteria
requiring clinical judgment or assessments.’ Indeed, all five
hospitals participating in our study reported difficulties with
the mapping of eligibility criteria to data elements
contained in the EHR. Codes from the ICD and OPS cata-
logues were preferred to encode patient characteristics
whenever possible. Other terminologies such as SNOMED
CT were not utilized by any of the participating hospitals.
Our study is limited to measuring data completeness,
which is only one of three fundamental dimensions of data
quality identified by Weiskopf and Weng [21]. They define
data completeness as the fraction of patients that has
some value documented for a given patient characteristic.
Additionally, data correctness represents the fraction of
available data that is true for the patient and data currency
represents the fraction of data that is documented before a
specified point in time. Data correctness is the major con-
cern of clinical researchers towards secondary use [22].
The data quality of the most valuable data source identi-
fied in our study, billing data in the form of ICD and OPS
codes, has already been investigated by many research
teams. Even though many sources of errors exist in the
course of the coding process [23], a review of 21 studies
on coding accuracy in the United Kingdom [24] found the
diagnosis codes to be accurate for 96.5% for ICD7, 87% for
ICD8 and 77% for ICD9. A very high accuracy of 97% was
also found for procedure codes (OPS). Laboratory data
can be regarded as correct when it is transferred directly
from the laboratory device to the EHR without human
intervention. Compared to the amount of missing data
in the EHR, we believe that incorrectness of data is of
minor influence to the feasibility of concrete secondary
use measures.
When beginning this work, we expected electronic
support of patient recruitment to follow the commonly
presented process of (1) translation of eligibility criteria
into an electronic form, (2) comparison of the electronic
criteria with existing patient data, (3) presenting the user
with a list of patients that (a) fulfil all inclusion criteria
and (b) do not fulfil any exclusion criterion. From the
experience gained from the data analysis we believe dir-
ect translation from the eligibility criteria of a trial is
currently not an efficient approach. System developers
also need to consider the completeness of EHR data and
how it fits the required patient characteristics. Otherwise
many patients will not be presented to the investigator
due to lack of data, thus risking that the included set of
patients is not representative of the target population. In
most cases, the selection of EHR data elements will
therefore require the involvement of the documenting
physicians and nurses. Often, an intelligent presentationof patient data for screening combined with well-placed
reminders will be more helpful to the investigator than
the attempt to assess the eligibility of patients.
If patient care and research are to interlock more tightly
both parties need to improve towards this goal. Electronic
documentation of patient history and treatment process is
currently still too fragmented for some secondary use pur-
poses. More and more documentation should be captured
electronically. In particular, incentives are needed to con-
vince physicians to document more data in a structured
form within the EHR. To promote this process medical in-
formatics can function as a catalyst by providing tools and
knowledge on how to capture and evaluate data. The
greatest challenge hereby is to strike a balance between
the physician’s ‘freedom of expression’ and the researcher’s
need for structure and standardization. The development
of free text processing tools to transform and extract
structured data from free text will be an important tool to
mediate between both worlds.
Conclusions
There exists a significant gap in structure and content
between data documented during patient care and data
required for patient eligibility assessment. Because of the
high fraction of missing data, developers of computer-
ized recruitment support systems need to be careful
which data elements to include into the screening
process. Nevertheless, EHR data on age and gender of
the patient, as well as selected information on his disease
can be complete enough to allow for an effective support
of the manual screening process with an intelligent pre-
selection of patients and patient data.
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